809273-65-2

Basic information

• Product Name: (4,4-Difluorocyclohexyl)methanamine HCl
• Synonyms: (4,4-Difluorocyclohexyl)methanamine HCl;(4,4-difluorocyclohexyl)MethanaMinehydrochloride;(4,4-Difluorocyclohexyl)methylamine hydrochloride;(4,4-Difluorocyclohexane)methylamine hydrochloride
• CAS NO: 809273-65-2
• Molecular Formula: C7H14ClF2N
• Molecular Weight: 186
• Mol File: 809273-65-2.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 214.3°C at 760 mmHg
• Flash Point: 83.4°C
• Appearance: /
• Vapor Pressure: 0.13mmHg at 25°C
• CAS DataBase Reference: (4,4-Difluorocyclohexyl)methanamine HCl(CAS DataBase Reference)
• NIST Chemistry Reference: (4,4-Difluorocyclohexyl)methanamine HCl(809273-65-2)
• EPA Substance Registry System: (4,4-Difluorocyclohexyl)methanamine HCl(809273-65-2)

Safety Data

• Hazardous Substances Data: 809273-65-2(Hazardous Substances Data)

Usage

Uses

(4,4-Difluorocyclohexyl)methanamine hcl

InChI:InChI=1/C7H13F2N.ClH/c8-7(9)3-1-6(5-10)2-4-7;/h6H,1-5,10H2;1H

Upstream product

• 809273-70-9 (4-oxo-cyclohexylmethyl)-carbamic acid tert-butyl ester 
• 809273-64-1 tert-butyl (4,4-difluorocyclohexyl)methylcarbamate 

Relevant articles and documents

Therapeutic Compounds

Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Therapeutic Compounds

Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF I

Compounds of Formula I, or pharmaceutically acceptable salts thereof: (chemical formula to be inserted here - please see paper copy) I wherein R1, R2, R3, R4, R5, and G are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.